Canine and feline B7-2 proteins, compositions and uses thereof

Details Canine and feline B7-2 proteins, compositions and uses thereof Canine and feline B7-2 proteins, compositions and uses thereof

2006-05-30

2006-05-30

Gambel, Phillip (Department: 1644)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C530S351000, C514S008100, C514S012200, C514S021800

Reexamination Certificate

active

07053181

ABSTRACT:
The present invention relates to B7 proteins; to B7 nucleic acid molecules, including those that encode such B7 proteins; to antibodies raised against such B7 proteins; and to therapeutic compounds that regulate B7 function. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.

REFERENCES:
patent: 5580756 (1996-12-01), Linsley et al.
patent: 6084067 (2000-07-01), Freeman et al.
patent: WO 95/03408 (1995-02-01), None
patent: WO 95/06738 (1995-03-01), None
patent: WO 95/23859 (1995-09-01), None
Maher et al. J. Immunol., 1996, vol. 157(9), pp. 3838-3844.
Lazetic et al. J. Biol. Chem., 2002, vol. 277(41), pp. 38660-38668.
Burgess et al., J. Cell Biol. 1990, vol. 111, pp. 2129-2138.
Lazar et al., Mol. Cell. Biol. 1988, vol. 8, pp. 1247-1252.
Metzler et al., Nature Structural Biol. 1997, vol. 4, pp. 527-531.
Bowie et al., Science 1990, vol. 247, pp. 1306-1310.
Attwood, Science 2000, vol. 290, pp. 471-473.
Skolnick et al., Trends in Biotech. 2000, vol. 18, pp. 34-39.
Pinelli et al., 1997, Immunology, Dec. 1997, vol. 92, No. Suppl. 1, p. 39.
Sharpe et al., Nature Reviews Immunology, 2002, 2 : 116-126.
Azuma et al., 1993,Nature,vol. 366, pp. 76-79.
Borriello et al., 1995,J. of Immunol.,vol. 155, pp. 5490-5497.
Carlesimo et al., 1997,Clin Exp Immunol,vol. 109, pp. 406-411.
Freeman et al., 1989,J. of Immunol.,vol. 143, pp. 2714-2722.
Freeman et al., 1993,J. Exp. Med.,vol. 178, pp. 2185-2192.
Freeman et al., 1993,Science,vol. 262, pp. 909-911.
Freeman et al., 1995,Immunity,vol. 2, pp. 523-532.
Fukumoto et al., 1998,Nature Biotechnology,vol. 16, pp. 267-270.
Gause et al., 1997,Immunology Today,vol. 18, No. 3, pp. 115-120.
Gause et al., 1997,J. of Immunol.,vol. 158, pp. 4082-4087.
Greenwald et al., 1997,J. of Immunol.,vol. 158, pp. 4088-4096.
Inobe et al., 1994,Biochemical and Biophysical Research Communications,vol. 200, No. 1, pp. 443-449.
Isono and Seto, 1995,Immunogenetics,vol. 42, pp. 217-220.
Iwasaki et al., 1997,J. of Immunol.,vol. 158, pp. 4591-4601.
Judge et al., 1995,International Immunology,vol. 7, No. 2, pp. 171-178.
Keane-Myers et al., 1997,J. of Immunol.,vol. 158, pp. 2042-2049.
Kuchroo et al., 1995,Cell,vol. 80, pp. 707-718.
Linsley et al., 1991,J. Exp. Med.,vol. 173, pp. 721-730.
Linsley et al., 1994,Immunity,vol. 1, pp. 793-801.
Morton et al., 1996,J. of Immunol.,vol. 156, pp. 1047-1054.
Reiser et al., 1992,Proc. Natl. Acad. Sci. USA,vol. 89, pp. 271-275.
Selvakumar et al., 1992,Immunogenetics,vol. 36, pp. 175-181.
Tsuji et al., 1997,Eur. J. Immunol.,vol. 27, pp. 782-787.
Jackerott et al., Genbank Accession No. U10925, 1994.
Jackerott et al., Genbank Accession No. 507873, 1994.
Goodman et al., Genbank Accession No. U31330, 1995.
Goodman et al., Genbank Accession No. 940937, 1995.
Isono, T., Genbank Accession No. 755097, 1995.
Isono and Seto, Genbank Accession No. D49843, 1995.
Hash et al., Genbank Accession No. U57755, 1996.
Hash and Collisson, Genbank Accession No. 2065521, 1996.
Borriello, F., et al., 1994,J. Immuno.,vol. 153, pp. 5038-4048.
Davis, T.A., et al., 1996,Int. Immunol.,vol. 7, pp. 1099-1111.
Freeman, G.J., et al., 1991,J. Exp. Med.,vol. 174, pp. 625-631.
Guo, Y., et al., 1995,J. Exp. Med.,vol. 181, pp. 1345-1355.
Jellis, C.L., et al., 1995,Immunogenetics,vol. 42, pp. 85-89.
Maeda, K., et al., 1997,Int. Immunol.,vol., 9, pp. 993-1000.
Maher, S.E., et al., 1996,J. Immuno.,vol. 157, pp. 3838-3844.
Selvakumar, A., et al., 1993,Immunogenetics,vol. 38, pp. 292-295.
Yang, et al., 1998,FASEB Journal for Experimental Biology, 12:5,pp. a940, XP002107311.
EMBL Accession No. U57755, “Felis catus T-cell specific surface glycoprotein B7-1 mRNA,” complete cds . 1996.
Hash, S.M., May 1997,Dissertation, Vetrinary Microbiology,Texas A&M University.
Yang, S., et al., April 18-22, 1998,FASEB Journal for Experimental Biology,12(5):a940, No. 5444 (Mar. 1998).

Affiliated with

Also associated with

Rating

Canine and feline B7-2 proteins, compositions and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Canine and feline B7-2 proteins, compositions and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine and feline B7-2 proteins, compositions and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3576908